Seroquel Prolong Forðatafla 50 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

seroquel prolong forðatafla 50 mg

cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 50 mg

Seroquel Prolong Forðatafla 300 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

seroquel prolong forðatafla 300 mg

cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 300 mg

Seroquel Prolong Forðatafla 200 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

seroquel prolong forðatafla 200 mg

cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 200 mg

Seroquel Prolong Forðatafla 150 mg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

seroquel prolong forðatafla 150 mg

cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 150 mg

Caverject Dual Stungulyfsstofn og leysir, lausn 10 míkróg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

caverject dual stungulyfsstofn og leysir, lausn 10 míkróg

pfizer aps - alprostadilum inn - stungulyfsstofn og leysir, lausn - 10 míkróg

Caverject Dual Stungulyfsstofn og leysir, lausn 20 míkróg Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

caverject dual stungulyfsstofn og leysir, lausn 20 míkróg

pfizer aps - alprostadilum inn - stungulyfsstofn og leysir, lausn - 20 míkróg

Fabrazyme Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

fabrazyme

sanofi b.v. - agalsidasa beta - fabry sjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - fabrazyme er ætlað til langtíma ensímuppbótarmeðferðar hjá sjúklingum með staðfestan sjúkdóm af fabry-sjúkdómum (α-galaktósíðasa-a skort).

Qtrilmet Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

qtrilmet

astrazeneca ab - sjúklingar stutt og long-term, saxagliptin, dapagliflozin - sykursýki, tegund 2 - lyf notuð við sykursýki - qtrilmet er ætlað í fullorðnir 18 ára og eldri með tegund sykursýki 2:til að bæta blóðsykursstjórnun þegar sjúklingar með eða án sulphonylurea (su) og annaðhvort saxagliptin eða dapagliflozin veitir ekki fullnægjandi blóðsykursstjórnun. þegar þegar í meðferð með sjúklingar og saxagliptin og dapagliflozin.

Azacitidine Mylan Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

azacitidine mylan

mylan ireland limited - azasitidín - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - Æxlishemjandi lyf - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Artesunate Amivas Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

artesunate amivas

amivas ireland ltd - artesunate - malaría - krabbamein - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. Íhuga ætti að opinbera leiðsögn á réttri notkun malaríulyf lyfjum.